Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -163,893 | -81,423 | -303,091 | -215,510 | -144,522 |
| Depreciation Amortization | 4,658 | 2,372 | 8,821 | 6,525 | 4,321 |
| Accounts receivable | -965 | 1,070 | -11,300 | -6,394 | -2,044 |
| Accounts payable and accrued liabilities | -6,844 | -9,675 | -3,722 | -10,291 | -9,730 |
| Other Working Capital | 2,549 | -14,325 | -42,436 | -39,882 | -25,036 |
| Other Operating Activity | 48,334 | 30,128 | 94,915 | 76,665 | 53,434 |
| Operating Cash Flow | $-116,161 | $-71,853 | $-256,813 | $-188,887 | $-123,577 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -636 | -252 | -3,233 | -2,180 | -1,920 |
| Purchase Of Investment | -386,025 | -222,248 | -50,353 | -30,695 | N/A |
| Sale Of Investment | 29,500 | N/A | 65,696 | 62,496 | 47,670 |
| Investing Cash Flow | $-357,161 | $-222,500 | $12,110 | $29,621 | $45,750 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 431,123 | N/A | N/A |
| Common Stock Issued | 51,294 | 2,583 | 53,142 | 50,267 | 4,083 |
| Other Financing Activity | -1,095 | -981 | -49,930 | -3,103 | -2,011 |
| Financing Cash Flow | $50,199 | $1,602 | $434,335 | $47,164 | $2,072 |
| Exchange Rate Effect | -446 | -147 | 319 | 220 | 259 |
| Beginning Cash Position | 687,153 | 687,153 | 497,202 | 497,202 | 497,202 |
| End Cash Position | 263,584 | 394,255 | 687,153 | 385,320 | 421,706 |
| Net Cash Flow | $-423,569 | $-292,898 | $189,951 | $-111,882 | $-75,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -116,161 | -71,853 | -256,813 | -188,887 | -123,577 |
| Capital Expenditure | -636 | -252 | -3,233 | -2,180 | -1,920 |
| Free Cash Flow | -116,797 | -72,105 | -260,046 | -191,067 | -125,497 |